354 related articles for article (PubMed ID: 29409903)
1. Cholinesterases and the fine line between poison and remedy.
Pope CN; Brimijoin S
Biochem Pharmacol; 2018 Jul; 153():205-216. PubMed ID: 29409903
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Potential of Multifunctional Tacrine Analogues.
Przybyłowska M; Kowalski S; Dzierzbicka K; Inkielewicz-Stepniak I
Curr Neuropharmacol; 2019; 17(5):472-490. PubMed ID: 29651948
[TBL] [Abstract][Full Text] [Related]
3. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
4. Diagnoses of Pathological States Based on Acetylcholinesterase and Butyrylcholinesterase.
Pohanka M
Curr Med Chem; 2020; 27(18):2994-3011. PubMed ID: 30706778
[TBL] [Abstract][Full Text] [Related]
5. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
6. Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.
Martinez A; Castro A
Expert Opin Investig Drugs; 2006 Jan; 15(1):1-12. PubMed ID: 16370929
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
8. Slow-binding inhibition of cholinesterases, pharmacological and toxicological relevance.
Masson P; Lushchekina SV
Arch Biochem Biophys; 2016 Mar; 593():60-8. PubMed ID: 26874196
[TBL] [Abstract][Full Text] [Related]
9. Protease inhibitors and indolamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer's disease.
Wright CI; Geula C; Mesulam MM
Ann N Y Acad Sci; 1993 Sep; 695():65-8. PubMed ID: 8239315
[TBL] [Abstract][Full Text] [Related]
10. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
Wright CI; Geula C; Mesulam MM
Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
[TBL] [Abstract][Full Text] [Related]
11. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
[TBL] [Abstract][Full Text] [Related]
12. [Cholinesterases and their importance in the etiology, diagnosis and therapy of Alzheimer's disease].
Patocka J; Strunecká A; Rípová D
Cesk Fysiol; 2001 Feb; 50(1):4-10. PubMed ID: 11268561
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Cholinesterases From Multiple Large Animal Species for Medical Countermeasure Development Against Chemical Warfare Nerve Agents.
McGarry KG; Schill KE; Winters TP; Lemmon EE; Sabourin CL; Harvilchuck JA; Moyer RA
Toxicol Sci; 2020 Mar; 174(1):124-132. PubMed ID: 31879781
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
[TBL] [Abstract][Full Text] [Related]
15. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
[TBL] [Abstract][Full Text] [Related]
16. Aqueous extract of Securidaca longipendunculata Oliv. and Olax subscropioidea inhibits key enzymes (acetylcholinesterase and butyrylcholinesterase) linked with Alzheimer's disease in vitro.
Saliu JA; Olabiyi AA
Pharm Biol; 2017 Dec; 55(1):252-257. PubMed ID: 27927065
[TBL] [Abstract][Full Text] [Related]
17. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
[TBL] [Abstract][Full Text] [Related]
18. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
19. Molecular Modeling Studies on the Multistep Reactivation Process of Organophosphate-Inhibited Acetylcholinesterase and Butyrylcholinesterase.
Jończyk J; Kukułowicz J; Łątka K; Malawska B; Jung YS; Musilek K; Bajda M
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33513955
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
Korabecny J; Musilek K; Holas O; Binder J; Zemek F; Marek J; Pohanka M; Opletalova V; Dohnal V; Kuca K
Bioorg Med Chem Lett; 2010 Oct; 20(20):6093-5. PubMed ID: 20817518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
